• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Mushrooms Evolved The Ability To Make Psilocybin Twice Independently, For Mysterious Reasons

September 26, 2025 by Deborah Bloomfield

Somehow, for reasons that are still unclear, the natural world gave rise to tiny mushrooms teeming with the psychoactive compound psilocybin. Even more astonishingly, the ability to produce this particular psychedelic didn’t evolve just once – it emerged at least twice independently.

Psilocybin is a naturally occurring psychedelic substance that profoundly alters consciousness and perception. While it can be used as a recreational (and illicit) drug to induce powerful trips, recent years have shown it also holds great promise in medicine, emerging as a potential treatment for therapy-resistant depression and other mental health conditions.

The chemical is most famously produced by around 165 different species belonging to the genus Psilocybe. However, it’s also made by part of another genus of mushroom-forming fungi, Inocybe, known as fiber caps.

For the first time, scientists in Germany and Austria have shown that the two fungal genera developed the ability to produce psilocybin at least twice independently of each other.

Psilocybe species make the substance using a known toolkit of enzymes. Surprisingly, they found that fiber cap mushrooms create it with a totally different biochemical arsenal, yet arrive at the same molecule.

“It was like looking at two different workshops, but both ultimately delivering the same product. In the fiber caps, we found a unique set of enzymes that have nothing to do with those found in Psilocybe mushrooms. Nevertheless, they all catalyze the steps necessary to form psilocybin,” Tim Schäfer, lead author of the study from the Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute (Leibniz-HKI), said in a statement.

This suggests the ability to produce psilocybin may be an example of convergent evolution – the process by which different organisms from different periods or regions independently evolve the same attributes or abilities due to similar evolutionary pressures. 

One well-known example is wings, which have evolved separately in birds, bats, insects, and other animals, all serving the same function of powered flight despite arising from very different parts of the tree of life. 

The question is, however, what drove the need for these two different fungi to co-evolve the same psychedelic compound?

“The real answer is: we don’t know,” said Professor Dirk Hoffmeister, head of the research group Pharmaceutical Microbiology at Friedrich Schiller University Jena and Leibniz-HKI. “Nature does nothing without reason. So there must be an advantage to both fiber cap mushrooms in the forest and Psilocybe species on manure or wood mulch producing this molecule – we just don’t know what it is yet.”

“One possible reason could be that psilocybin is intended to deter predators. Even the smallest injuries cause Psilocybe mushrooms to turn blue through a chemical chain reaction, revealing the breakdown products of psilocybin. Perhaps the molecule is a type of chemical defense mechanism,” added Hoffmeister.



Whatever the answer, the latest breakthrough could guide the way towards new, easier ways to synthesize psilocybin, as it shows there’s not one path towards making this mind-altering molecule.

“We hope that our results will contribute to the future production of psilocybin for pharmaceuticals in bioreactors without the need for complex chemical syntheses,” added Schäfer.

The study is published in the journal Angewandte Chemie International Edition.

Deborah Bloomfield
Deborah Bloomfield

Related posts:

  1. GrubMarket gobbles up $120M at a $1B+ pre-money valuation to take on the grocery supply chain
  2. Japanese octogenarian skateboarder learns new tricks
  3. Cyborgs V “Holdout Humans”: What The World Might Be Like If Our Species Survives For A Million Years
  4. Atlas V Carrying Final National Security Mission Launches Today – Watch Here

Source Link: Mushrooms Evolved The Ability To Make Psilocybin Twice Independently, For Mysterious Reasons

Filed Under: News

Primary Sidebar

  • “Unidentified Human Relative”: Little Foot, One Of Most Complete Early Hominin Fossils, May Be New Species
  • Thought Arctic Foxes Only Came In White? Think Again – They Come In Beautiful Blue Too
  • COVID Shots In Pregnancy Are Safe And Effective, Cutting Risk Of Hospitalization By 60 Percent
  • Ramanujan’s Unexpected Formulas Are Still Unraveling The Mysteries Of The Universe
  • First-Ever Footage of A Squid Disguising Itself On Seafloor 4,100 Meters Below Surface
  • Your Daily Coffee Might Be Keeping You Young – Especially If You Have Poor Mental Health
  • Why Do Cats And Dogs Eat Grass?
  • What Did Carl Sagan Actually Mean When He Said “We Are All Made Of Star Stuff”?
  • Lonesome George: The Giant Tortoise Who Was The Very Last Of His Kind
  • Bermuda Sits On A Strange, 20-Kilometer-Thick Structure That’s Like No Other In The World
  • Time Moves Faster Up A Mountain – And That’s Why Earth’s Core Is 2.5 Years Younger Than Its Surface
  • Bio-Hybrid Robots Made Of Dead Lobsters Are The Latest Breakthrough In “Necrobotics”
  • Why Do Some Italians Live To 100? Turns Out, Centenarians Have More Hunter-Gatherer DNA
  • New Full-Color Images Of Interstellar Comet 3I/ATLAS, As We Are Days Away From Closest Encounter
  • Hilarious Video Shows Two Young Andean Bears Playing Seesaw With A Tree Branch
  • The Pinky Toe Has A Purpose And Most People Are Just Finding Out
  • What Is This Massive Heat-Emitting Mass Discovered Beneath The Moon’s Surface?
  • The Man Who Fell From Space: These Are The Last Words Of Cosmonaut Vladimir Komarov
  • How Long Can A Bird Can Fly Without Landing?
  • Earliest Evidence Of Making Fire Has Been Discovered, X-Rays Of 3I/ATLAS Reveal Signature Unseen In Other Interstellar Objects, And Much More This Week
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version